Literature DB >> 11533281

Dietary conjugated linoleic acid modulates phenotype and effector functions of porcine CD8(+) lymphocytes.

J Bassaganya-Riera1, R Hontecillas, D R Zimmerman, M J Wannemuehler.   

Abstract

In vivo vaccination and challenge studies have demonstrated that CD8(+) lymphocytes are essential for the development of cell-mediated protection against intracellular pathogens and neoplastic cells. Depletion of peripheral blood CD8(+) cells interferes with clearance of viruses and intracellular fungi, induction of delayed type hypersensitivity responses and antitumoral activity. In contrast to humans or mice, porcine peripheral CD8(+) lymphocytes are characterized by a heterogeneous expression pattern (i.e., CD8alphabeta and CD8alphaalpha) that facilitates the study of distinctive traits among minor CD8(+) cell subsets. A factorial (2 x 2) arrangement within a split-plot design, with 16 blocks of two littermate pigs as the experimental units for immunization treatment (i.e., unvaccinated or vaccinated with a proteinase-digested Brachyspira hyodysenteriae bacterin) and pig within block as the experimental unit for dietary treatment (soybean oil or conjugated linoleic acid) were used to investigate the phenotypic and functional regulation of CD8(+) cells by dietary conjugated linoleic acid (CLA). Dietary CLA supplementation induced in vivo expansion of porcine CD8(+) cells involving T-cell receptor (TCR)gammadeltaCD8alphaalpha T lymphocytes, CD3(-)CD16(+)CD8alphaalpha (a porcine natural killer cell subset), TCRalphabetaCD8alphabeta T lymphocytes and enhanced specific CD8(+)-mediated effector functions (e.g., granzyme activity). Expansion of peripheral blood TCRalphabetaCD8alphabeta cells was positively correlated (r = 0.89, P < 0.01) with increased percentages of CD8alphabeta(+) thymocytes. Functionally, CLA enhanced the cytotoxic potential of peripheral blood lymphocytes and proliferation of TCRgammadeltaCD8alphaalpha cells. Collectively, these results indicate that dietary CLA enhances cellular immunity by modulating phenotype and effector functions of CD8(+) cells involved in both adaptive and innate immunity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11533281     DOI: 10.1093/jn/131.9.2370

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  7 in total

1.  Similar effects of c9,t11-CLA and t10,c12-CLA on immune cell functions in mice.

Authors:  D S Kelley; J M Warren; V A Simon; G Bartolini; B E Mackey; K L Erickson
Journal:  Lipids       Date:  2002-07       Impact factor: 1.880

Review 2.  Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease.

Authors:  Josep Bassaganya-Riera; Raquel Hontecillas
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-09       Impact factor: 4.294

3.  CD4+ T-cell responses and distribution at the colonic mucosa during Brachyspira hyodysenteriae-induced colitis in pigs.

Authors:  Raquel Hontecillas; Josep Bassaganya-Riera; Jennifer Wilson; David L Hutto; Michael J Wannemuehler
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

Review 4.  Modulation of body composition and immune cell functions by conjugated linoleic acid in humans and animal models: benefits vs. risks.

Authors:  D S Kelley; K L Erickson
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

Review 5.  Prevention of mammary cancer with conjugated linoleic acid: role of the stroma and the epithelium.

Authors:  Margot M Ip; Patricia A Masso-Welch; Clement Ip
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-01       Impact factor: 2.673

6.  Influence of conjugated linoleic acid on the porcine immune response and morbidity: a randomized controlled trial.

Authors:  Tomaz Malovrh; Lidija Kompan; Polona Juntes; Branka Wraber; Alenka Spindler-Vesel; Drago Kompan
Journal:  Lipids Health Dis       Date:  2009-06-22       Impact factor: 3.876

7.  Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis.

Authors:  Josep Bassaganya-Riera; Monica Viladomiu; Mireia Pedragosa; Claudio De Simone; Adria Carbo; Rustem Shaykhutdinov; Christian Jobin; Janelle C Arthur; Benjamin A Corl; Hans Vogel; Martin Storr; Raquel Hontecillas
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.